Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU

NCT02343575 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02343575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02343575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
Lead sponsor
Stanford University
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2015
Completion date
January 31, 2018
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperactive delirium, mixed delirium